Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46
CONMED Corporation
CONMED Corporation CNMD | 0.00 |
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:
CNMD) with a Equal-Weight and raises the price target from $39 to $46.